<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01060696</url>
  </required_header>
  <id_info>
    <org_study_id>615/2551</org_study_id>
    <nct_id>NCT01060696</nct_id>
  </id_info>
  <brief_title>Efficacy of Mefenamic Acid and Hyoscine for Pain Relief During Saline Infusion Sonohysterography in Infertile Women</brief_title>
  <official_title>Efficacy of Mefenamic Acid and Hyoscine for Pain Relief During Saline Infusion Sonohysterography in Infertile Women. A Double Blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Siriraj Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The infertility patients who are performed saline infusion sonohysterography (SIS) for
      studying the pathology inside the uterine cavity has pain. From pilot study the pain score is
      6.80. It will have more benefits if we can manage this procedure with less or no pain. Many
      studies have tried to decrease pain such as types of catheter, intrauterine lidocaine
      infusion. Some have real effects but no study with oral Mefenamic acid or Hyoscine before the
      procedure.The drugs are safe and easy to administration and chief.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">May 2010</completion_date>
  <primary_completion_date type="Anticipated">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain relief by oral Mefenamic acid or Hyoscine and placebo during saline infusion sonohysterography</measure>
    <time_frame>Before, during and after the procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients satisfaction during saline infusion sonohysterography</measure>
    <time_frame>After the procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Hyoscine, Mefenamic acid, Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blind randomization to three groups. Mefenamic acid group Hyoscine group Placebo group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mefenamic acid or Hyoscine or placebo</intervention_name>
    <description>Mefenamic acid 500 mg. single oral use 30 minutes before SIS Hyoscine 10 mg. single oral use 30 minutes before SIS Placebo single oral use 30 minutes before SIS</description>
    <arm_group_label>Hyoscine, Mefenamic acid, Placebo</arm_group_label>
    <other_name>Ponstan (Mefenamic acid)</other_name>
    <other_name>Buscopan (Hyoscine-N-butylbromide)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infertility female

          -  no history of HSG or Hysteroscopy

        Exclusion Criteria:

          -  vaginal or pelvic infection

          -  abnormal Pap smear

          -  contraindications for Mefenamic acid including upper and lower GI ulcers, bleeding
             disorder, Asthma or allergies, renal disease, using Warfarin,Aspirin, Lithium, history
             of Mefenamic acid or Hyoscine allergies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Singpetch Suksompong, Doctor</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Siriraj hospital Mahidol university</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2010</study_first_submitted>
  <study_first_submitted_qc>February 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2010</study_first_posted>
  <last_update_submitted>February 1, 2010</last_update_submitted>
  <last_update_submitted_qc>February 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Singpetch Suksompong</name_title>
    <organization>Mahidol University</organization>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>Saline infusion sonohysterography</keyword>
  <keyword>Pain</keyword>
  <keyword>Hyoscine</keyword>
  <keyword>Mefenamic acid</keyword>
  <keyword>women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scopolamine Hydrobromide</mesh_term>
    <mesh_term>Butylscopolammonium Bromide</mesh_term>
    <mesh_term>Mefenamic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

